MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study.

MLA

Martin-Broto, Javier, et al. “MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study.” Molecular Cancer Therapeutics, vol. 13, no. 1, Jan. 2014, pp. 249–59. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-13-0406.

APA

Martin-Broto, J., Gutierrez, A. M., Ramos, R. F., Lopez-Guerrero, J. A., Ferrari, S., Stacchiotti, S., Picci, P., Calabuig, S., Collini, P., Gambarotti, M., Bague, S., Dei Tos, A. P., Palassini, E., Luna, P., Cruz, J., Cubedo, R., Martinez-Trufero, J., Poveda, A., Casali, P. G., … Gronchi, A. (2014). MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study. Molecular Cancer Therapeutics, 13(1), 249–259. https://doi.org/10.1158/1535-7163.MCT-13-0406

Chicago

Martin-Broto, Javier, Antonio M Gutierrez, Rafael F Ramos, José A Lopez-Guerrero, Stefano Ferrari, Silvia Stacchiotti, Piero Picci, et al. 2014. “MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study.” Molecular Cancer Therapeutics 13 (1): 249–59. doi:10.1158/1535-7163.MCT-13-0406.